They’re Testing It in Top U.S. Hospitals Right Now. Are You Still Watching from the Sidelines?
Heart failure is everywhere and it’s not just your grandpa’s problem anymore. It’s affecting dads in their 50s, moms in their early 60s, and people in their 30s who “just felt a little off.”
And Future Cardia? They’re not waiting around. They’re out there, right now, testing their life-saving device at some of the best heart hospitals in the United States.
This isn’t theoretical, it's happening in real clinics, on real people, and you can still be part of it.
The $40 Billion Problem We Still Haven’t Solved
Let’s be honest, America spends a lot of money treating heart failure after it’s already gone too far. We’re talking:
- 1 million+ ER visits a year
- $40 billion in costs
- And way too many “we didn’t catch it in time” moments
Wearables try to help but they can’t catch everything and let’s face it, people forget to wear them. They fall off, the batteries die, and then what?
Future Cardia’s implant doesn’t get left on a charger, it goes under the skin, it watches 24/7, it sends early alerts before that ER visit ever happens, and it’s already been tested in 39 patients, collecting over 60,000 hours of live heart data.
This isn’t a maybe. This is what’s next.
A Real American Underdog and a Real Investment Opportunity
If you’ve ever wished you got in early on Medtronic or Boston Scientific, here’s your second shot. Future Cardia is backed by:
- Stanford StartX
- Johnson & Johnson’s JLABS
- $15M already raised from over 10,000 investors
They’re aiming at a slice of a $65B+ global market, dominated by just three legacy players. And as history shows, when small medtech companies get it right, the exits are big, think $500 million to over $1 billion.
But here’s the part most people miss:
The current investment round closes on June 20. After that, valuation changes. Terms change, your window? Gone.
And the best part? You don’t need to be a Silicon Valley VC to get in, you can invest with as little as $348.
Act Now, Before the Story Becomes Someone Else’s Win
So here’s the deal, they’re testing it in Florida. They’ve already proven the device works, they’re submitting to the FDA this November.
You can either keep watching from the sidelines, or make your move while it still counts.
Because if this thing really changes cardiac care in the U.S.? You’ll want to say, “I was in before everyone else caught on.”
Invest in Future Cardia on...
*This product is not yet available for purchase and requires review and clearance before being marketed or sold. This Reg CF offering is made available through StartEngine Primary, LLC. This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment.